Figure 1.

Changes in total Sharp score, erosion, and joint-space narrowing at 2 years in patients who had early rheumatoid arthritis (RA) and were given etanercept or methotrexate (MTX). These were the data from the open-label extension phase of the Early Rheumatoid Arthritis trial [28].

Schwartzman et al. Arthritis Res Ther 2004 6(Suppl 2):S3-S11   doi:10.1186/ar1013